Powercheck AI is a Malaysian health technology startup developing an integrated platform for genetic testing and health management. The company offers a product suite including PowerDNA Premium for whole genome sequencing, PowerDNA Starter for basic genetic analysis, and PowerCheck, a non-invasive screening device that uses palm detection to analyze body systems. Additionally, Powercheck AI sells DNATide, a personalized peptide supplement protocol based on customer genetic data. Powercheck AI employs a closed-loop business model designed to acquire customers using low-cost screening tools or supplements and subsequently upsell them to high-value genetic testing and recurring subscription services. The company distributes its products through direct-to-consumer digital channels and B2B partnerships with corporate wellness programs, pharmacies, and clinics. Growth initiatives focus on expanding within Malaysia and eventually into broader Southeast Asian markets, including Singapore and Thailand. A key component of this strategy involves launching physical health centers to provide in-person screenings and medical services. Powercheck AI operates through a VIE structure where a BVI holding company controls its Malaysian operating entity. The company also intends to monetize aggregated health data through partnerships with insurers and pharmaceutical researchers.